HCHyerin Choi

Hyerin Choi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hyerin Choi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Ali Jawad

    Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea; Institute of Stem Cell and Regenerative Medicine (ISCRM), Chungbuk National University, Cheongju, Republic of Korea

    5 shared publications
  • Dongjin Oh

    Veterinary Medical Center and College of Veterinary Medicine, Laboratory of Veterinary Embryology and Biotechnology (VETEMBIO), Chungbuk National University, Cheongju 28644, Korea

    5 shared publications
  • Jaehyung Ham

    Center and College of Veterinary Medicine, Chungbuk National University, Cheongju, South Korea; Institute of Stem Cell and Regenerative Medicine (ISCRM), Chungbuk National University, Cheongju, South Korea

    3 shared publications
  • Byoung Chol Oh

    2 shared publications
  • Eunsong Lee

    Department of Theriogenology, College of Veterinary Medicine, Kangwon National University, Chuncheon 24341, Republic of Korea

    2 shared publications
  • Huijin Jin

    2 shared publications

Latest Publications

  • Open Access

    FGF8–FGFR4 signaling supports porcine oocyte developmental competence by regulating EGA-associated gene expression and mitochondrial function

    by Jaehyung Ham, Dongjin Oh, Hyerin Choi, Ali Jawad, Zheng Haomiao, Juyoung Heo, Huijin Jin, Jaehyeok Seo, Seokyung Lee, Byoung Chol Oh, et al.

    Fibroblast growth factor 8 (FGF8) has been implicated as an oocyte-associated regulator of follicular function and oocyte developmental competence. Our previous study showed that FGF8 supplementation during porcine in vitro maturation (IVM) improves oocyte maturation and subsequent embryonic development, while FGFR4 is predominantly detected in porcine oocytes. This study investigated whether FGF8 promotes porcine oocyte maturation and early embryonic developmental competence through FGFR4-associated signaling. Porcine cumulus–oocyte complexes were matured in vitro with FGF8, BLU9931, a selective irreversible FGFR4 inhibitor, or both. Nuclear maturation, cumulus expansion, parthenogenetic activation embryo development, downstream phosphorylation responses, embryonic genome activation (EGA)-associated gene expression, mitochondrial function, and apoptosis were evaluated. FGF8 increased pFGFR4 and pFRS2 fluorescence intensity, improved nuclear maturation, cumulus expansion, and blastocyst formation, and enhanced phosphorylation of MAPK, AKT, and STAT3. In contrast, BLU9931 suppressed FGFR4 phosphorylation, reduced meiotic maturation and cumulus expansion, and almost completely blocked blastocyst formation. Co-treatment with FGF8 and BLU9931 failed to restore these developmental outcomes. In 4-cell embryos, FGF8 increased EGA-associated gene expression, mitochondrial membrane potential, and ATP-associated fluorescence, whereas FGFR4 inhibition attenuated these effects. Annexin V/PI staining showed no significant increase in embryonic apoptosis or membrane integrity loss after BLU9931 treatment. These findings indicate that FGF8 supports porcine oocyte maturation and early embryonic development largely through FGFR4-associated signaling during IVM. FGFR4 appears to contribute to developmental competence acquisition by regulating downstream phosphorylation responses, EGA-associated molecular programming, and mitochondrial functional readiness.

  • Open Access

    Effect of erythropoietin supplementation during in vitromaturation on the developmental competence of porcine oocytes

    by Juyoung Heo, Dongjin Oh, Hyerin Choi, Ali Jawad, Jaehyung Ham, Zheng Haomiao, Huijin Jin, Jaehyeok Seo, Seokyung Lee, Byoung Chol Oh, et al.

    Porcine oocyte in vitro maturation (IVM) remains suboptimal because current culture systems do not fully recapitulate the follicular environment present in vivo. Erythropoietin (EPO), a cytoprotective factor reported in the ovarian follicular compartment, may contribute to the regulation of oocyte maturation; While, its role during porcine IVM remains unclear. This study investigated the presence and localization of EPO in porcine ovarian follicles and evaluated whether EPO supplementation during IVM improves oocyte developmental competence. EPO immunoreactivity was detected in porcine oocytes and surrounding follicular cells across multiple follicular stages. Porcine cumulus-oocyte complexes were then cultured in IVM medium supplemented with 0, 10, 100, or 1000 mU/mL EPO for 42 h. Nuclear maturation rates did not differ among groups, whereas 100 mU/mL EPO significantly increased blastocyst formation following parthenogenetic activation. EPO treatment was also associated with increased mitochondrial membrane potential-related fluorescence and MitoTracker fluorescence, reduced intracellular reactive oxygen species levels, increased BCL-2 expression, and reduced CASP3-related apoptotic signals. These findings suggest that EPO supplementation during porcine oocyte IVM improves subsequent developmental competence and is associated with improved mitochondrial status, reduced oxidative stress, and attenuated apoptotic stress.

  • Open Access

    Functional characterization of the ability of FGF8 to enhance porcine oocyte maturation

    by Jaehyung Ham, Dongjin Oh, Hyerin Choi, Ali Jawad

    Fibroblast growth factor 8 (FGF8) is known to act as an oocyte-secreted factor (OSF) of oocyte maturation in several mammalian species. However, its expression and function in the porcine ovary remain largely unexplored. This study aimed to investigate the localization patterns of FGF8 and its receptors, fibroblast growth factor receptor 3c (FGFR3c) and fibroblast growth factor receptor 4 (FGFR4), during follicular development, and to evaluate the effects of FGF8 supplementation during in vitro maturation (IVM) of porcine cumulus–oocyte complexes (COCs). Immunohistochemistry (IHC) revealed that FGF8 was present in both oocytes and surrounding somatic cells, FGFR3c was primarily localized to somatic cells, and FGFR4 was detected mainly in oocytes. Supplementation with FGF8 during IVM enhanced nuclear maturation, cytoplasmic maturation, cumulus expansion, and subsequent embryonic development, as compared to the controls. In particular, treatment with 100 ng/mL FGF8 significantly increased the expression of mRNA associated with glycolysis, antioxidative response, and anti-apoptotic pathways in cumulus cells, and upregulated the expression of OSFs and maternal-effect genes (MEGs) in oocytes. These molecular changes support the notion that FGF8 facilitates oocyte developmental competence via both metabolic and protective mechanisms. Collectively, our findings demonstrate, for the first time, the spatial expression of FGF8 and its receptors in porcine ovaries and confirm that FGF8 positively regulates porcine oocyte maturation through transcriptional changes in both cumulus cells and oocytes.

  • Open Access

    Developmental competence of chimeric porcine embryos through the aggregation of parthenogenetic embryos and somatic cell nuclear transfer embryos

    by Joohyeong Lee, Lian Cai, Mirae Kim, Hyerin Choi, Dongjin Oh, Ali Jawad, Eunsong Lee, Sang-Hwan Hyun

    The efficiency of somatic cell nuclear transfer (NT) in pigs is low and requires enhancement. We identified the most efficient method for zona pellucida (ZP) removal and blastomere aggregation in pigs and investigated whether the aggregation of NT and parthenogenetic activation (PA) of blastomeres could reduce embryonic apoptosis and improve the quality of NT-derived embryos by investigating. Embryonic developmental competence after ZP removal using acid Tyrode's solution or protease (pronase E). The embryonic developmental potential of NT-derived blastomeres was also investigated using well-of-the-well or phytohemagglutinin-L. We analyzed apoptosis in aggregate-derived blastocysts. The aggregation rate of protease-treated embryos was lower than that of Tyrode’s solution-treated embryos (69.2% vs. 88.3%). No significant difference was observed between phytohemagglutinin-L and well-of-the-well (35.7%–38.5%). However, 2P1N showed a higher number of blastocysts compared to 3N (73.8% vs. 24.3%) and an increased blastocyst diameter compared to the control and 1P2N (274 μm vs. 230–234 μm). In blastomeres aggregated using phytohemagglutinin-L, the apoptotic cell ratio was significantly higher in 1P2N and 3N than in 3P (5.91%–6.46% vs. 2.94%, respectively). Our results indicate that aggregation of one NT embryo with two PA embryos improved the rate of blastocysts with increased blastocyst diameter.

  • Open Access

    Antioxidant effect of ergothioneine on in vitro maturation of porcine oocytes

    by Ji-Young Jeong, Lian Cai, Mirae Kim, Hyerin Choi, Dongjin Oh, Ali Jawad, Sohee Kim, Haomiao Zheng, Eunsong Lee, Joohyeong Lee, et al.

    Jeong JY, et al. J Vet Sci. 2023 Feb;24:e24. https://doi.org/10.4142/jvs.22204


  • Real-Time ECG Monitoring System Using Optical Implantable Cardiac Monitor

    by Seung-Kyu Choi, Illsoo Sohn, Woo-Hyun Kim, Chohee Kim, Sungho Park, Hyun-Ju Lee, Haeil Lim, Younghyo Cho, Changhyeon Choi, Hyerin Choi

    본 논문에서는 광통신 기반의 인체삽입형 심전도계(implantable cardiac monitor)를 이용하여 실시간으로 심전도를 모니터링하는 디지털헬스케어 시스템를 구현하였다. 인체삽입형 심전도계는 제한된 배터리 용량으로도 작동수명을 최대화하기 위해 LED 펄스를 이용하는 초 저전력 변조방식을 적용하였다. 체외의 광수신기는 전송받은 생체신호를 근거리 무선통신 기술을 이용하여 안드로이드 단말기로 전송한다. 원격으로 수집한 심전도 데이터는 안드로이드 단말과 서버에서 다양한 신호처리 방법을 통해 건강 이상유무를 판단하고 도식화한다. 제안하는 실시간 심전도 모니터링 시스템은 직접 구현한 하드웨어 프로토타입으로 검증하였다.